Mono Pharmacare Ltd vs Pfizer Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 11, 2026

Key Highlights

The Latest Trading Price of Mono Pharmacare Ltd is ₹ 13.1 as of 06 May 15:30 . The P/E Ratio of Mono Pharmacare Ltd is 0 as of March 2023 .The P/E Ratio of Pfizer Ltd is 0 as of March 2023 . The Market Cap of Mono Pharmacare Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Pfizer Ltd is ₹ 0 crore as of March 2023 . The revenue of Mono Pharmacare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Pfizer Ltd for the Dec '25 is ₹ 683.24 crore as compare to the Sep '25 revenue of ₹ 684.19 crore. This represent the decline of -0.14% The ebitda of Mono Pharmacare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Pfizer Ltd for the Dec '25 is ₹ 208.2 crore as compare to the Sep '25 ebitda of ₹ 271.78 crore. This represent the decline of -23.39% The net profit of Mono Pharmacare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Pfizer Ltd changed from ₹ 150.71 crore to ₹ 141.84 crore over 7 quarters. This represents a CAGR of -3.41% The Dividend Payout of Mono Pharmacare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Pfizer Ltd changed from 32.18 % on March 2021 to 98.34 % on March 2025 . This represents a CAGR of 25.03% over 5 years .

About Mono Pharmacare Ltd

Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of 'M/s.
Mono Chemist' through Partnership Deed dated May 06, 1994.
The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad.
The Company is engaged in the business of marketing and distribution of pharmaceutical products. The product portfolio comprises of a wide range of drugs like Antibiotics, Antifungal, Anti CoughCold & Anti-allergic, Antacid and Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare, Antiseptic, Cardiac and Diabetic & Cosmetics etc. getting products manufactured through contract manufacturing. Supal Distributors LLP, a Partnership Firm, was incorporated on November 24, 2016, with the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya, being the Original Partners.

About Pfizer Ltd

Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories.
It has its own manufacturing facility at Goa and Thane.
It has the distinction of being the first pharmaceutical company in India to start clinical research.
The Company sells products in nearly 185 countries having 43 manufacturing sites globally.

FAQs for the comparison of Mono Pharmacare Ltd and Pfizer Ltd

Which company has a larger market capitalization, Mono Pharmacare Ltd or Pfizer Ltd?

Market cap of Mono Pharmacare Ltd is 23 Cr while Market cap of Pfizer Ltd is 22,009 Cr

What are the key factors driving the stock performance of Mono Pharmacare Ltd and Pfizer Ltd?

The stock performance of Mono Pharmacare Ltd and Pfizer Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mono Pharmacare Ltd and Pfizer Ltd?

As of May 11, 2026, the Mono Pharmacare Ltd stock price is INR ₹13.1. On the other hand, Pfizer Ltd stock price is INR ₹4811.05.

How do dividend payouts of Mono Pharmacare Ltd and Pfizer Ltd compare?

To compare the dividend payouts of Mono Pharmacare Ltd and Pfizer Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.